|
|
|
Insider
Information: |
Evnin Luke |
Relationship: |
10% Owner |
City: |
Boston |
State: |
MA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
15 |
|
Direct
Shares |
330,044 |
|
Indirect Shares
|
35,767,143 |
|
|
Direct
Value |
$449,921 |
|
|
Indirect Value
|
$126,433,068 |
|
|
Total
Shares |
36,097,187 |
|
|
Total
Value |
$126,882,990 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
1
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
1
|
|
|
|
Gain/Loss Ratio : |
0.0
|
-1.0
|
Percentage
Gain/Loss : |
0.0%
|
-18.7%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Oscient Pharmaceuticals Corp |
OSCIQ |
Director |
|
0 |
2006-01-05 |
2,272,935 |
Premium* |
|
Idenix Pharmaceuticals Inc |
IDIX |
10% Owner |
2004-07-27 |
0 |
2004-07-27 |
4,797,991 |
Premium* |
|
Rigel Pharmaceuticals Inc |
RIGL |
10% Owner |
2004-07-02 |
0 |
2004-07-02 |
1,833,597 |
Premium* |
|
iPass Inc |
IPAS |
10% Owner |
2004-02-09 |
26,043 |
2004-02-09 |
262,533 |
Premium* |
|
Hemosense Inc |
HEM |
10% Owner |
2005-07-01 |
0 |
2007-11-06 |
0 |
Premium* |
|
American Cryostem Corporation |
CRYO |
10% Owner |
2005-07-13 |
0 |
2005-07-19 |
2,931,531 |
Premium* |
|
Radius Health Inc. |
RDUS |
Former 10% stockholder |
|
0 |
2016-09-27 |
3,887,502 |
Premium* |
|
Pacira Pharmaceuticals, Inc. |
PCRX |
Director |
2013-06-13 |
0 |
2013-06-13 |
824,255 |
Premium* |
|
Syndax Pharmaceuticals Inc |
SNDX |
Director, 10% Owner |
2016-03-08 |
0 |
2016-03-08 |
2,168,691 |
Premium* |
|
Harpoon Therapeutics, Inc. |
HARP |
Former 10% Owner |
2019-02-12 |
0 |
2021-04-15 |
3,220,844 |
Premium* |
|
Repare Therapeutics Inc. |
RPTX |
10% Owner |
2020-06-23 |
0 |
2020-06-23 |
3,003,772 |
Premium* |
|
Oncorus, Inc. |
ONCR |
Director, 10% Owner |
|
0 |
2020-10-06 |
2,492,843 |
Premium* |
|
Turmeric Acquisition Corp. |
TMPM |
Chief Executive Officer |
2020-10-20 |
0 |
2020-10-20 |
415,500 |
Premium* |
|
Werewolf Therapeutics, Inc. |
HOWL |
Director, 10% Owner |
|
0 |
2021-05-04 |
4,284,172 |
Premium* |
|
Tcr2 Therapeutics Inc. |
TCRR |
10% Owner |
2023-05-22 |
304,001 |
2023-05-22 |
3,370,977 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
107 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 4 of 5
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
HOWL |
Werewolf Therapeutics, In... |
Director |
|
2021-05-04 |
4 |
A |
$0.00 |
$0 |
I/I |
3,671,965 |
4,133,373 |
0 |
- |
|
OSCIQ |
Oscient Pharmaceuticals C... |
Director |
|
2005-09-14 |
4 |
S |
$2.45 |
$58,756 |
I/I |
(23,975) |
4,166,075 |
|
- |
|
OSCIQ |
Oscient Pharmaceuticals C... |
Director |
|
2005-09-13 |
4 |
S |
$2.44 |
$121,855 |
I/I |
(50,000) |
4,190,050 |
|
- |
|
OSCIQ |
Oscient Pharmaceuticals C... |
Director |
|
2005-09-12 |
4 |
S |
$2.44 |
$500,938 |
I/I |
(205,000) |
4,240,050 |
|
- |
|
HARP |
Harpoon Therapeutics, Inc... |
Director |
|
2019-02-12 |
4 |
D |
$14.00 |
$21,336 |
I/I |
(1,524) |
4,274,425 |
0 |
- |
|
HARP |
Harpoon Therapeutics, Inc... |
Director |
|
2019-02-12 |
4 |
OE |
$0.05 |
$21,260 |
I/I |
432,119 |
4,275,949 |
0 |
- |
|
HOWL |
Werewolf Therapeutics, In... |
Director |
|
2021-05-04 |
4 |
B |
$16.00 |
$2,412,784 |
I/I |
150,799 |
4,284,172 |
2.25 |
- |
|
HEM |
Hemosense Inc |
10% Owner |
|
2005-07-01 |
4 |
B |
$5.50 |
$4,214,980 |
I/I |
766,360 |
4,303,719 |
1.5 |
- |
|
HARP |
Harpoon Therapeutics, Inc... |
10% Owner |
|
2021-01-26 |
4 |
AS |
$21.08 |
$28,732 |
I/I |
(1,363) |
4,339,955 |
0 |
% |
|
HARP |
Harpoon Therapeutics, Inc... |
10% Owner |
|
2021-01-25 |
4 |
AS |
$21.23 |
$276,117 |
I/I |
(13,006) |
4,341,318 |
0 |
% |
|
HARP |
Harpoon Therapeutics, Inc... |
10% Owner |
|
2021-01-22 |
4 |
AS |
$21.72 |
$536,375 |
I/I |
(24,695) |
4,354,324 |
0 |
% |
|
HARP |
Harpoon Therapeutics, Inc... |
10% Owner |
|
2021-01-21 |
4 |
AS |
$22.11 |
$579,095 |
I/I |
(26,066) |
4,379,019 |
0 |
% |
|
HARP |
Harpoon Therapeutics, Inc... |
10% Owner |
|
2021-01-20 |
4 |
AS |
$0.00 |
$0 |
I/I |
(101,646) |
4,405,085 |
0 |
% |
|
OSCIQ |
Oscient Pharmaceuticals C... |
Director |
|
2005-09-09 |
4 |
S |
$2.51 |
$250,980 |
I/I |
(100,000) |
4,445,050 |
|
- |
|
HARP |
Harpoon Therapeutics, Inc... |
10% Owner |
|
2021-01-20 |
4 |
AS |
$23.95 |
$425,291 |
I/I |
(17,694) |
4,506,731 |
0 |
% |
|
HARP |
Harpoon Therapeutics, Inc... |
Director |
|
2019-02-12 |
4 |
B |
$14.00 |
$3,500,000 |
I/I |
250,000 |
4,524,425 |
2.25 |
- |
|
OSCIQ |
Oscient Pharmaceuticals C... |
Director |
|
2005-09-06 |
4 |
S |
$2.47 |
$602,046 |
I/I |
(242,000) |
4,545,050 |
|
- |
|
RDUS |
Radius Health Inc. |
10% Owner |
|
2014-06-06 |
4 |
A |
$0.00 |
$0 |
I/I |
4,743,002 |
4,743,002 |
0 |
- |
|
OSCIQ |
Oscient Pharmaceuticals C... |
Director |
|
2005-08-31 |
4 |
S |
$2.30 |
$3,475,000 |
I/I |
(1,500,000) |
4,787,050 |
|
- |
|
IDIX |
Idenix Pharmaceuticals In... |
10% Owner |
|
2004-07-27 |
4 |
S |
$14.00 |
$7,117,194 |
I/I |
(508,371) |
4,797,991 |
|
- |
|
RDUS |
Radius Health Inc. |
10% Owner |
|
2008-06-15 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
5,000,000 |
|
- |
|
IDIX |
Idenix Pharmaceuticals In... |
10% Owner |
|
2004-07-21 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
5,306,362 |
|
- |
|
RDUS |
Radius Health Inc. |
10% Owner |
|
2014-06-06 |
4 |
A |
$0.00 |
$0 |
I/I |
1,088,251 |
5,831,253 |
0 |
- |
|
OSCIQ |
Oscient Pharmaceuticals C... |
Director |
|
2005-08-30 |
4 |
S |
$2.28 |
$228,000 |
I/I |
(100,000) |
6,287,050 |
|
- |
|
OSCIQ |
Oscient Pharmaceuticals C... |
Director |
|
2005-08-24 |
4 |
S |
$2.23 |
$446,000 |
I/I |
(200,000) |
6,387,050 |
|
- |
|
107 Records found
|
|
Page 4 of 5 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|